Results 301 to 310 of about 1,464,129 (347)
Some of the next articles are maybe not open access.
Clinical and Translational Oncology, 2005
The clinical status of terminal cancer patients is very complex and is affected by several severe symptoms, of extended duration, changing with time and of multifactorial origin. When there are no reasonable cancer treatments specifically able to modify the natural history of the disease, symptom control acquires priority and favours the possible ...
Manuel, González Barón +2 more
openaire +2 more sources
The clinical status of terminal cancer patients is very complex and is affected by several severe symptoms, of extended duration, changing with time and of multifactorial origin. When there are no reasonable cancer treatments specifically able to modify the natural history of the disease, symptom control acquires priority and favours the possible ...
Manuel, González Barón +2 more
openaire +2 more sources
Oncogenes and clinical oncology
Current Opinion in Oncology, 1991The past year has seen important advances in our understanding of the molecular biology of human cancer. We have learned more about how normal genes with critical functions in growth and development can induce cellular transformation and malignancy if mutated or overexpressed.
W H, Miller, E, Dmitrovsky
openaire +2 more sources
CANCER AND METASTASIS REVIEW, 1988
Positron Emission Tomography (PET) is an imaging technique that produces cross sectional images based on tissue biochemical and physiological processes. PET complements other anatomic imaging techniques such as x-ray CT and magnetic resonance imaging (MRI).
R A, Hawkins, M E, Phelps
openaire +2 more sources
Positron Emission Tomography (PET) is an imaging technique that produces cross sectional images based on tissue biochemical and physiological processes. PET complements other anatomic imaging techniques such as x-ray CT and magnetic resonance imaging (MRI).
R A, Hawkins, M E, Phelps
openaire +2 more sources
1997
18-FDG is accumulated in cancer cells. It has been proven useful to image a variety of tumors in conjunction with whole-body positron emission tomography. This review details some of the indications of PET at various stages of the cancerous process: differential diagnosis, preoperative staging, diagnosis of residual or recurrent disease as well as ...
Rigo, P. +7 more
openaire +2 more sources
18-FDG is accumulated in cancer cells. It has been proven useful to image a variety of tumors in conjunction with whole-body positron emission tomography. This review details some of the indications of PET at various stages of the cancerous process: differential diagnosis, preoperative staging, diagnosis of residual or recurrent disease as well as ...
Rigo, P. +7 more
openaire +2 more sources
Clinical Investigative Neuro-oncology
Archives of Internal Medicine, 1986The major thrust of the investigative work going on in the neurosurgical laboratories at Duke University, Durham, NC, in the late 1950s centered about mechanisms of regional perfusion or infusion of chemical agents into the carotid circulation. The rationale was that such technical advances might permit a more concentrated entry of antineoplastic ...
openaire +2 more sources
Clinical Journal of Oncology Nursing
Health-related stigma, including cancer-related stigma, can lead to discrimination that contributes to health inequities and poor health-related outcomes.This article provides a scholarly foundation to acknowledge and address health-related stigma in clinical oncology care.This comprehensive clinical literature review is based on peer-reviewed articles
openaire +2 more sources
Health-related stigma, including cancer-related stigma, can lead to discrimination that contributes to health inequities and poor health-related outcomes.This article provides a scholarly foundation to acknowledge and address health-related stigma in clinical oncology care.This comprehensive clinical literature review is based on peer-reviewed articles
openaire +2 more sources
Clinical Positron Imaging, 1998
The major utilization of clinical PET is in oncology, and oncologic PET utilizes FDG as the radiopharmaceutical. FDG imaging demonstrates the increased metabolism by malignant cells compared to normal cells. The initial clinical application of FDG-PET was demonstrated in brain tumors, and the gradation of accumulation of FDG related to the degree of ...
openaire +2 more sources
The major utilization of clinical PET is in oncology, and oncologic PET utilizes FDG as the radiopharmaceutical. FDG imaging demonstrates the increased metabolism by malignant cells compared to normal cells. The initial clinical application of FDG-PET was demonstrated in brain tumors, and the gradation of accumulation of FDG related to the degree of ...
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly